Atossa Genetics
Price & Volume
Stats
See more52W Range | $1.70-$19.35 |
Market Cap | $23.5M |
Shares Short | 704,017 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.39 |
News
See moreYahoo Finance • last month
Top Midday Decliners
Yahoo Finance • last month
Atossa Therapeutics prices up to $16.5M direct offering
Yahoo Finance • 2 months ago
Atossa Gets FDA Rare Pediatric Disease Tag For (Z)-Endoxifen In McCune-Albright Syndrome
Yahoo Finance • 4 months ago
Atossa Therapeutics GAAP EPS of -$4.04 misses by $0.22
About
CEO | Dr. Steven C. Quay FCAP, M.D., Ph.D. |
Address | 448 NW Market Street, Seattle, WA, United States, 98107 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 16 |